Yahoo Web Search

  1. Yahoo Finance Results

  2. Better Buy: Intuitive Surgical vs. Johnson & Johnson

    Motley Fool via Yahoo FinanceDec 04 20:38 PM

    Intuitive Surgical (NASDAQ: ISRG) and Johnson & Johnson (NYSE: JNJ) are two healthcare giants that look poised to ride the megatrend of increased medical spending for years to ...

  3. In that same time, the Medical sector gained 6.05%, while the S&P 500 gained 3.57%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $20.11 billion, down 0.42% ...

    147.10+0.60 (+0.41%)

    at Wed, Dec 12, 2018, 16:01PM EST - U.S. Markets open in 7 hrs 32 mins

    After Hours 147.10 N/A (N/A%)

    Delayed Quote

    • Open 147.00
    • High 148.49
    • Low 147.00
    • 52 Wk. High 148.99
    • 52 Wk. Low 118.62
    • Mkt. Cap 394.52B
  4. MSFT, Johnson & Johnson JNJ, Chevron Corp. CVX and Pfizer Inc. PFE. The Dow traversed a particularly difficult holiday-shortened week.

  5. Boris Johnson said the U.K. is on the brink of a “historic mistake,” comparing Theresa May’s Brexit plan to the Titanic heading toward disaster. To help avoid the return of checkpoints ...

  6. When it comes to drug pricing, Johnson & Johnson’s CEO says he’s open to change. CEO Alex Gorsky tells Fortune, “Obviously you’ve got to work with payers, providers.

  7. Here are highlights from Wednesday’s Analyst Blog: Top Analyst Reports for Johnson & Johnson, Thermo Fisher and Goldman Sachs The Zacks Research Daily presents the best research ...

  8. To keep it practical, we’ll show how Johnson Service Group PLC’s (LON:JSG) P/E ratio could help you assess the value on offer. Johnson Service Group has a price to earnings ratio ...

  9. Former foreign minister Boris Johnson said on Sunday that British Prime Minister Theresa May should publish the legal advice she was given on her Brexit deal, joining calls by the main ...

  10. Johnson & Johnson: An Excellent Business Selling at a Rational Price

    GuruFocus.com via Yahoo FinanceDec 05 20:53 PM

    Johnson & Johnson has grown earnings per share by a compound annual rate of 10.5% per year over the last two decades, by 6% per annum in the last decade and 8.2% annualized over ...

  11. Wall Street expects a year-over-year decline in earnings on higher revenues when Johnson Outdoor (JOUT) reports results for the quarter ended September 2018. While this widely-known consensus ...